Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s00705-020-04768-3 http://scihub22266oqcxt.onion/10.1007/s00705-020-04768-3 32778950!7416802!32778950     free     free     free       Arch+Virol 2020 ; 165 (11): 2419-2438 Nephropedia Template TP {{tp|p=32778950|t=2020. Potential strategies for combating COVID-19 |pdf=|usr=}}{{32778950}} gab.com Text Potential strategies for combating COVID-19 JO: Arch Virol http://www.kidney.de/pget.php?&tw=1&pmid=32778950 #FOAvip Coronavirus disease 2019, also known as COVID-19, is caused by a novel coronavirus named severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2. The infection has now catapulted into a full-blown pandemic across the world, which has affected more than 2 million people and has led to approximately 150,000 fatalities all over the world (WHO). In this review, we elaborate all currently available data that shed light on possible methods for treatment of COVID-19, such as antiviral drugs, corticosteroids, convalescent plasma, and potentially effective vaccines. Additionally, ongoing and discontinued clinical trials that have been carried out for validating probable treatments for COVID-19 are discussed. The review also elaborates the prospective approach and the possible advantages of using convalescent plasma and stem cells for the improvement of clinical symptoms and meeting the demand for an instantaneous cure. Twit Text FOAVip Potential strategies for combating COVID-19 ????Arch Virol http://www.kidney.de/pget.php?&tw=1&pmid=32778950 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32778950 #FOAvip English Wikipedia <ref>{{Cite pmid|32778950}}</ref> Potential strategies for combating COVID-19 #MMPMID32778950 Shamim S; Khan M; Kharaba ZJ; Ijaz M; Murtaza G Arch Virol 2020[Nov]; 165 (11): 2419-2438 PMID32778950show ga Coronavirus disease 2019, also known as COVID-19, is caused by a novel coronavirus named severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2. The infection has now catapulted into a full-blown pandemic across the world, which has affected more than 2 million people and has led to approximately 150,000 fatalities all over the world (WHO). In this review, we elaborate all currently available data that shed light on possible methods for treatment of COVID-19, such as antiviral drugs, corticosteroids, convalescent plasma, and potentially effective vaccines. Additionally, ongoing and discontinued clinical trials that have been carried out for validating probable treatments for COVID-19 are discussed. The review also elaborates the prospective approach and the possible advantages of using convalescent plasma and stem cells for the improvement of clinical symptoms and meeting the demand for an instantaneous cure. |Adenosine Monophosphate/analogs & derivatives/therapeutic use[MESH] |Adrenal Cortex Hormones/therapeutic use[MESH] |Alanine/analogs & derivatives/therapeutic use[MESH] |Amides/therapeutic use[MESH] |Antibodies, Monoclonal, Humanized/therapeutic use[MESH] |Antiviral Agents/*therapeutic use[MESH] |Betacoronavirus/*drug effects/immunology/pathogenicity[MESH] |COVID-19[MESH] |COVID-19 Serotherapy[MESH] |COVID-19 Vaccines[MESH] |Coronavirus Infections/*drug therapy/immunology/pathology/prevention & control/therapy/virology[MESH] |Cytokine Release Syndrome/immunology/*prevention & control/virology[MESH] |Drug Combinations[MESH] |Humans[MESH] |Hydroxychloroquine/therapeutic use[MESH] |Immunization, Passive/methods[MESH] |Immunologic Factors/*therapeutic use[MESH] |Indoles/therapeutic use[MESH] |Interleukin 1 Receptor Antagonist Protein/therapeutic use[MESH] |Lopinavir/therapeutic use[MESH] |Pandemics[MESH] |Pneumonia, Viral/*drug therapy/immunology/pathology/virology[MESH] |Pyrazines/therapeutic use[MESH] |Ritonavir/therapeutic use[MESH] |SARS-CoV-2[MESH] |Severity of Illness Index[MESH]Potential strategies for combating COVID-19 (epmc).pdf DeepDyve Pubget Overpricing